Wells Fargo’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-44,200
Closed -$1.09M 7488
2022
Q3
$1.09M Buy
+44,200
New +$1.46M ﹤0.01% 3189
2020
Q3
Sell
-59,300
Closed -$20K 6356
2020
Q2
$20K Buy
+59,300
New +$750K ﹤0.01% 5697
2019
Q3
Sell
-21,600
Closed -$7K 6385
2019
Q2
$7K Buy
+21,600
New +$637K ﹤0.01% 5975

Other funds holding CC

Wells Fargo's CC Position: Q1 2026 in Review

Wells Fargo increased its Chemours (CC) stake by 121% in Q1 2026, buying an estimated $4.91M and bringing the position to 515,562 shares worth $11.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1931.

Wells Fargo first reported a position in CC in Q3 2015 and has held it in 43 quarters since. The position peaked at $24M in Q1 2021. 448 funds tracked by Wall St. Rank hold CC as of Q1 2026.

  • Wells Fargo held 515,562 shares of Chemours worth $11.4M as of Q1 2026.
  • Wells Fargo bought 281,948 Chemours shares in Q1 2026, an estimated $4.91M.
  • Chemours made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #1931 holding.
  • Wells Fargo first reported a position in Chemours in Q3 2015 and has held it in 43 quarters since.
  • Wells Fargo's Chemours position peaked at $24M in Q1 2021.
  • 448 funds tracked by Wall St. Rank held Chemours as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.